InDevR, Inc.

InDevR, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on April 22, 2019 and the most recent on April 22, 2019 (FluChip-8G Influenza A+B Assay). Its most common review panel is Microbiology (1 device).